Completion of a non-exclusive discount agreement According to § 130a para. 8 Sgb W To the active ingredient Benralizumab, Atc R03dx10 For The Time 01.06.2023 - 31.05.2025
To tender for the conclusion of non-exclusive medicament discounts according to § 130a para. 8 Sgb V In the way of a so-called open-house model To the active ingredient Tamsulosin/dutasterid (atc-code Who: G04ca52)'